The Effect Of Saffron ( Crocus Sativus L.) Supplementation On Blood Pressure, And Renal And Liver Function In Patients With Type 2 Diabetes Mellitus: A Double-blinded, Randomized Clinical Trial
Notes for this study:
||U/L. AST. Placebo: before 22.1±8.5, after 19.8±7.5. Saffron: before 22.4±10.3, after 21.2±8.8. ALT Placebo: before 23.6±11.1, after 20.8±11 Saffron: before 22.35±10.7, after. ALP Placebo: before 167.1±46.6, after 166.4±45.2. Saffron: before 177.1±49.6, after 172.3±45.8.
|Number of Subjects
||30-44, 45-64, 65+
In a randomized, double-blind, placebo-controlled trial, 80 participants with type 2 diabetes took 100 mg of saffron powder or placebo for 12 weeks.
There wasn't an effect on liver enzymes, creatinine, urea, or albumin. There was a reduction in systolic blood pressure but not diastolic.
The trial was preregistered: IRCT201510259472N9